Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01378390Phase 3Terminated
A Phase 3 trial of CX401 in perianal fistula, sponsored by TiGenix. Started Dec 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01378390.